company background image
ONEM

1Life Healthcare NasdaqGS:ONEM Stock Report

Last Price

US$16.96

Market Cap

US$3.3b

7D

0.1%

1Y

-40.8%

Updated

07 Aug, 2022

Data

Company Financials +
ONEM fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

ONEM Stock Overview

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand.

1Life Healthcare Competitors

Price History & Performance

Summary of all time highs, changes and price drops for 1Life Healthcare
Historical stock prices
Current Share PriceUS$16.96
52 Week HighUS$27.92
52 Week LowUS$5.94
Beta2.52
1 Month Change46.84%
3 Month Change152.01%
1 Year Change-40.82%
3 Year Changen/a
5 Year Changen/a
Change since IPO-23.15%

Recent News & Updates

Shareholder Returns

ONEMUS HealthcareUS Market
7D0.1%0.6%1.0%
1Y-40.8%12.6%-12.9%

Return vs Industry: ONEM underperformed the US Healthcare industry which returned 12.6% over the past year.

Return vs Market: ONEM underperformed the US Market which returned -12.9% over the past year.

Price Volatility

Is ONEM's price volatile compared to industry and market?
ONEM volatility
ONEM Average Weekly Movement24.5%
Healthcare Industry Average Movement9.6%
Market Average Movement7.9%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.2%

Stable Share Price: ONEM is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 25% a week.

Volatility Over Time: ONEM's weekly volatility has increased from 16% to 25% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20023,090Amir Rubinhttps://www.onemedical.com

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.

1Life Healthcare Fundamentals Summary

How do 1Life Healthcare's earnings and revenue compare to its market cap?
ONEM fundamental statistics
Market CapUS$3.31b
Earnings (TTM)-US$358.70m
Revenue (TTM)US$891.49m

3.7x

P/S Ratio

-9.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ONEM income statement (TTM)
RevenueUS$891.49m
Cost of RevenueUS$719.36m
Gross ProfitUS$172.13m
Other ExpensesUS$530.83m
Earnings-US$358.70m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.84
Gross Margin19.31%
Net Profit Margin-40.24%
Debt/Equity Ratio19.1%

How did ONEM perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is ONEM undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ONEM?

Other financial metrics that can be useful for relative valuation.

ONEM key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4x
Enterprise Value/EBITDA-14.7x
PEG Ration/a

Price to Sales Ratio vs Peers

How does ONEM's PS Ratio compare to its peers?

ONEM PS Ratio vs Peers
The above table shows the PS ratio for ONEM vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average5.2x
AMN AMN Healthcare Services
1x-16.9%US$5.1b
OSH Oak Street Health
4x27.5%US$7.3b
GH Guardant Health
13.3x23.3%US$5.4b
AMEH Apollo Medical Holdings
2.5xn/aUS$2.4b
ONEM 1Life Healthcare
3.7x21.9%US$3.3b

Price-To-Sales vs Peers: ONEM is good value based on its Price-To-Sales Ratio (3.7x) compared to the peer average (5.2x).


Price to Earnings Ratio vs Industry

How does ONEM's PE Ratio compare vs other companies in the US Healthcare Industry?

Price-To-Sales vs Industry: ONEM is expensive based on its Price-To-Sales Ratio (3.7x) compared to the US Healthcare industry average (1.5x)


Price to Sales Ratio vs Fair Ratio

What is ONEM's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ONEM PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3.7x
Fair PS Ratio2.5x

Price-To-Sales vs Fair Ratio: ONEM is expensive based on its Price-To-Sales Ratio (3.7x) compared to the estimated Fair Price-To-Sales Ratio (2.5x).


Share Price vs Fair Value

What is the Fair Price of ONEM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ONEM's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ONEM's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Future Growth

How is 1Life Healthcare forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


35.8%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ONEM is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ONEM is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ONEM is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ONEM's revenue (21.9% per year) is forecast to grow faster than the US market (8% per year).

High Growth Revenue: ONEM's revenue (21.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ONEM is forecast to be unprofitable in 3 years.


Discover growth companies

Past Performance

How has 1Life Healthcare performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-54.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ONEM is currently unprofitable.

Growing Profit Margin: ONEM is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ONEM is unprofitable, and losses have increased over the past 5 years at a rate of 54.7% per year.

Accelerating Growth: Unable to compare ONEM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ONEM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (7.7%).


Return on Equity

High ROE: ONEM has a negative Return on Equity (-22.08%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is 1Life Healthcare's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: ONEM's short term assets ($560.3M) exceed its short term liabilities ($216.5M).

Long Term Liabilities: ONEM's short term assets ($560.3M) do not cover its long term liabilities ($700.0M).


Debt to Equity History and Analysis

Debt Level: ONEM has more cash than its total debt.

Reducing Debt: Insufficient data to determine if ONEM's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ONEM has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: ONEM has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 43.4% each year.


Discover healthy companies

Dividend

What is 1Life Healthcare current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate ONEM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ONEM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ONEM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ONEM's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ONEM has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.9yrs

Average management tenure


CEO

Amir Rubin (52 yo)

5yrs

Tenure

US$1,788,721

Compensation

Mr. Amir Dan Rubin, MBA, has been the Chief Executive Officer and President at 1Life Healthcare, Inc. since August 2017 and has been its Chair, since September 2017. From January 2016 to August 2017, he se...


CEO Compensation Analysis

Compensation vs Market: Amir's total compensation ($USD1.79M) is below average for companies of similar size in the US market ($USD6.58M).

Compensation vs Earnings: Amir's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: ONEM's management team is considered experienced (2.9 years average tenure).


Board Members

Experienced Board: ONEM's board of directors are considered experienced (3.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 41.6%.


Top Shareholders

Company Information

1Life Healthcare, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: 1Life Healthcare, Inc.
  • Ticker: ONEM
  • Exchange: NasdaqGS
  • Founded: 2002
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: US$3.310b
  • Shares outstanding: 195.18m
  • Website: https://www.onemedical.com

Number of Employees


Location

  • 1Life Healthcare, Inc.
  • One Embarcadero Center
  • Suite 1900
  • San Francisco
  • California
  • 94111
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/07 00:00
End of Day Share Price2022/08/05 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.